Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Return on Assets (2023 - 2025)

Historic Return on Assets for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to 0.33%.

  • BioLineRx's Return on Assets rose 1600.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.38% for FY2024, which is N/A changed from last year.
  • Per BioLineRx's latest filing, its Return on Assets stood at 0.33% for Q3 2025, which was up 1600.0% from 0.36% recorded in Q2 2025.
  • BioLineRx's 5-year Return on Assets high stood at 0.33% for Q3 2025, and its period low was 0.81% during Q4 2023.
  • Moreover, its 3-year median value for Return on Assets was 0.46% (2024), whereas its average is 0.52%.
  • As far as peak fluctuations go, BioLineRx's Return on Assets soared by 3900bps in 2024, and later skyrocketed by 1600bps in 2025.
  • Quarter analysis of 3 years shows BioLineRx's Return on Assets stood at 0.81% in 2023, then surged by 48bps to 0.42% in 2024, then grew by 21bps to 0.33% in 2025.
  • Its Return on Assets was 0.33% in Q3 2025, compared to 0.36% in Q2 2025 and 0.42% in Q1 2025.